Company intelligence / Profile preview

杰成医疗

Suzhou, Jiangsu, Chinajcnico.com ↗

Ownership: Private
Employees: ~169
Development stage: Commercial

Overview

"杰成医疗" is a leading Chinese medical device company specializing in transcatheter heart valve technologies, notably the J-Valve system for aortic valve replacement. Its J-Valve product was among the first TAVR (Transcatheter Aortic Valve Replacement) devices approved and commercialized in China, with over three thousand implants by end of 2021. The company has achieved significant clinical adoption domestically and has begun international expansion, including successful cases in North America via special access programs. In early 2022, it was acquired by Genesis MedTech.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on 杰成医疗.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 杰成医疗.

Explore the full profile